4.7 Review

Magnitude and Time-Trend Analysis of Postendoscopy Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis

Journal

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 20, Issue 2, Pages E31-E50

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2021.04.032

Keywords

Missed Esophageal Adenocarcinoma; Quality; Endoscopy; Surveillance

Funding

  1. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [U34-DK124174, K08-DK119475]
  2. National Institutes of Health [T32-DK007038]
  3. University of Colorado Department of Medicine Outstanding Early Scholars Award

Ask authors/readers for more resources

This study aimed to estimate the proportion of postendoscopy esophageal adenocarcinoma (PEEC) within the first year after Barrett's esophagus (BE) diagnosis. The results showed a high proportion of PEEC among patients with EAC and EAC-F HGD, and the proportion was inversely related to incident EAC. It is necessary to use the best endoscopic techniques and implement quality measures and educational tools to improve neoplasia detection and reduce PEEC.
BACKGROUND & AIMS: Identification of postendoscopy esophageal adenocarcinoma (PEEC) among Barrett's esophagus (BE) patients presents an opportunity to improve survival of esophageal adenocarcinoma (EAC). We aimed to estimate the proportion of PEEC within the first year after BE diagnosis. METHODS: Multiple databases (Medline, Embase, Scopus, and Cochrane databases) were searched until September 2020 for original studies with at least 1-year follow-up evaluation that reported EAC and/or high-grade dysplasia (HGD) in the first year after index endoscopy in nondysplastic BE, low-grade dysplasia, or indefinite dysplasia. The proportions of PEEC defined using EAC alone and EAC-F HGD were calculated by dividing EAC or EAC-F HGD in the first year over the total number of EAC or EAC HGD, respectively. RESULTS: We included 52 studies with 145,726 patients and a median follow-up period of 4.8 years. The proportion of PEEC (EAC) was 21% (95% CI, 13-31) and PEEC (EAC-F HGD) was 26% (95% CI, 19-34). Among studies with nondysplastic BE only, the PEEC (EAC) proportion was 17% (95% CI, 11-23) and PEEC (EAC-F HGD) was 14% (95% CI, 8-19). Among studies with 5 or more years of follow-up evaluation, the PEEC (EAC) proportion was 10% and PEEC (EAC HGD) was 19%. Meta-regression analysis showed a strong inverse relationship between PEEC and incident EAC (P < .001). The PEEC (EAC) proportion increased from 5% in studies published before 2000 to 30% after 2015. Substantial heterogeneity was observed for most analyses. CONCLUSIONS: PEEC accounts for a high proportion of HGD/EACs and is proportional to reduction in incident EAC. Using best endoscopic techniques now and performing future research on improving neoplasia detection through implementation of quality measures and educational tools is needed to reduce PEEC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Immunology

Comparing Complication Rates of Midline Catheter vs Peripherally Inserted Central Catheter. A Systematic Review and Meta-analysis

Meritxell Urtecho, Victor D. Torres Roldan, Tarek Nayfeh, Nataly R. Espinoza Suarez, Nischal Ranganath, Priya Sampathkumar, Vineet Chopra, Nasia Safdar, Larry J. Prokop, John C. O'Horo

Summary: A systematic review and meta-analysis compared the complications of midline catheters and peripherally inserted central catheters (PICCs), focusing on catheter-related bloodstream infection (CRBSI) and thrombosis. The results showed that midline catheters were associated with fewer CRBSIs but a higher risk of superficial venous thrombosis compared to PICCs. These findings provide guidance for future cost-benefit analyses and direct comparative trials to better understand the efficacy and risks of midline catheters versus PICCs.

OPEN FORUM INFECTIOUS DISEASES (2023)

Review Medicine, General & Internal

The safety of intravenous peripheral administration of 3% hypertonic saline: A systematic review and meta-analysis

Jomana Madieh, Bashar Hasan, Iman Khamayseh, Alaa Hrizat, Tareq Salah, Tarek Nayfeh, Kamel Gharaibeh, Abdurrahman Hamadah

Summary: This article presents a systematic review and meta-analysis of the complications associated with peripheral infusion of 3% hypertonic saline (3% HTS). The study found that peripheral administration of 3% HTS has a low rate of complications and is considered a safe and possibly preferred option.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2023)

Review Cardiac & Cardiovascular Systems

Predictors of Mortality in Patients With Refractory Cardiac Arrest Supported With VA-ECMO: A Systematic Review and a Meta-Analysis

Anas Hashem, Mohamed Salah Mohamed, Khaled Alabdullah, Ahmed Elkhapery, Amani Khalouf, Samer Saadi, Tarek Nayfeh, Devesh Rai, Omar Alali, Elissa A. Kinzelman-Vesely, Vishal Parikh, Scott C. Feitell

Summary: This study analyzed and evaluated articles published between January 2000 and July 2022 to identify mortality-predicting factors in patients with CA supported with VA-ECMO. The study found that predictors of mortality include age >65, history of chronic kidney disease, cardiopulmonary resuscitation duration prior to ECMO >40 minutes, initial rhythm being non-shockable, and Sequential Organ Failure Assessment score >14. These findings are important for improving patient survival rates and guiding treatment decisions.

CURRENT PROBLEMS IN CARDIOLOGY (2023)

Article Critical Care Medicine

COVID-19 Infection Is Associated With Increased In-Hospital Mortality and Complications in Patients With Acute Heart Failure: Insight From National Inpatient Sample (2020)

Anas Hashem, Amani Khalouf, Mohamed Salah Mohamed, Tarek Nayfeh, Ahmed Elkhapery, Mohammad Elbahnasawy, Devesh Rai, Himanshu Deshwal, Scott Feitell, Sudarshan Balla

Summary: Patients with acute heart failure (AHF) exacerbation are at risk for complications when infected with COVID-19. Limited data exists on the clinical outcomes of COVID-19 in AHF patients. This study used a national inpatient sample database to compare AHF patients with and without COVID-19. It found that COVID-19 infection in AHF patients is associated with higher in-hospital mortality, need for mechanical ventilation, septic shock, and AKI, as well as longer hospital stays and higher costs. The study highlights the importance of understanding the impact of COVID-19 on AHF patients. Rating: 9/10

JOURNAL OF INTENSIVE CARE MEDICINE (2023)

Article Gastroenterology & Hepatology

MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses

Nabil Noureddin, Veeral Ajmera, Jaclyn Bergstrom, Richele Bettencourt, Daniel Q. Huang, Harris Siddiqi, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramzan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Rohit Loomba

Summary: MEFIB-Index and MAST-Score, which combine MRI-based biomarkers and blood tests, can predict the risk of hepatic decompensation in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Cardiac & Cardiovascular Systems

Outcomes of Percutaneous Atrial Septal Defect Closure With Mitral Transcatheter Edge-to-Edge Repair and Transseptal Mitral Valve Replacement (2015 to 2020)

Anas Hashem, Amani Khalouf, Mohamed Salah Mohamed, Mahmoud Ismayl, Anthony Kashou, Rody G. Bou Chaaya, Tarek Nayfeh, Devesh Rai, Samian Sulaiman, Sudarshan Balla

Summary: This study used the National Inpatient Sample to evaluate the clinical outcomes of percutaneous closure of ASD after TEER and TMVR procedures. It was found that the rate of percutaneous closure of ASD was higher in TMVR cases and was associated with higher in-hospital mortality and longer hospital stays. Further clinical trials are needed to identify patients who would benefit from closure of iatrogenic ASD.

AMERICAN JOURNAL OF CARDIOLOGY (2023)

Article Gastroenterology & Hepatology

Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis

Daniel Q. Huang, Nabil Noureddin, Veeral Ajmera, Maral Amangurbanova, Ricki Bettencourt, Emily Truong, Tolga Gidener, Harris Siddiqi, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Masato Yoneda, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Alina M. Allen, Mazen Noureddin, Rohit Loomba

Summary: The presence of type 2 diabetes in patients with NAFLD is associated with a significantly higher risk of hepatic decompensation and hepatocellular carcinoma.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

IABP USE IN ADHF-CS PATIENTS AND ITS IMPACT ON CARDIAC HEMODYNAMIC INDICES, DETERIORATION AND MORTALITY.

Khaled Alabdallah, Tarek Nayfeh, Samer Saadi, Shazia Aziz, Mohammad Aldiabat, Edward Wilson Grandin, Arthur R. Garan

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Article Gastroenterology & Hepatology

Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality

Sung Won Lee, Daniel Q. Huang, Ricki Bettencourt, Veeral Ajmera, Monica Tincopa, Nabil Noureddin, Maral Amangurbanova, Harris Siddiqi, Egbert Madamba, Abdul M. Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Masato Yoneda, Ramzan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Rohit Loomba

Summary: Low liver fat content in patients with NASH-related significant fibrosis and cirrhosis is associated with an increase in hepatic decompensation, HCC, and mortality.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Review Cardiac & Cardiovascular Systems

Feasibility and Safety of Intracardiac Echocardiography Guidance in Mitral Transcatheter Edge-to-Edge Repair: Analysis of the National Inpatient Sample Data From 2015 to 2020

Anas Hashem, Amani Khalouf, Ankit Agrawal, Mohamad Salah Mohamad, Tarek Nayfeh, Anthony Kashou, Rody G. Bou Chaaya, Devesh Rai, Basil Verghese, Stephen H. Little, Andrew Goldsweig, Srihari Naidu, Sachin S. Goel

Summary: This study evaluated the feasibility, safety, and clinical outcomes of intracardiac echocardiography (ICE) guided mitral transcatheter edge-to-edge repair (mTEER) procedure. The results showed no significant differences in in-hospital mortality, complications, and hospital costs compared to transesophageal echocardiography (TEE) guided mTEER.

CURRENT PROBLEMS IN CARDIOLOGY (2024)

Meeting Abstract Gastroenterology & Hepatology

NATURAL HISTORY OF HEPATIC DECOMPENSATION AND LIVER-RELATED OUTCOMES IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Nabil Noureddin, Daniel Huang, Richele Bettencourt, Harris Siddiqi, Abdul Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Emily Truong, Tolga Gidener, Alina M. Allen, Mazen Noureddin, Veeral Ajmera, Rohit Loomba

GASTROENTEROLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

TYPE OF DONOR LIVER TRANSPLANT DOES NOT AFFECT PREGNANCY OUTCOMES - A SYSTEMATIC REVIEW AND META-ANALYSIS

Karim Osman, Tarek Nayfeh, Judy Alrukby, Neev N. Mehta, Asahi Hoque, Carol Spencer, Lina Elkhabiry, Rowan Elhamamy

GASTROENTEROLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

PREGNANCY OUTCOMES IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS - A SYSTEMATIC REVIEW AND META-ANALYSIS

Karim Osman, Tarek Nayfeh, Neev N. Mehta, Carol Spencer, Anastasia Naritsin, Lina Elkhabiry, Rowan Elhamamy

GASTROENTEROLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

HEPATIC DECOMPENSATION AND HEPATOCELLULAR CARCINOMA RISK IN NONALCOHOLIC FATTY LIVER DISEASE AMONG PATIENTS WITH DIABETES VERSUS PATIENTS WITHOUT DIABETES: SYSTEMATIC REVIEW AND INDIVIDUAL PATIENT DATA META-ANALYSIS

Daniel Huang, Nabil Noureddin, Veeral Ajmera, Maral Amangurbanova, Richele Bettencourt, Emily Truong, Tolga Gidener, Harris Siddiqi, Tarek Nayfeh, Abdul Majzoub, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Mazen Noureddin, Alina M. Allen, Rohit Loomba

GASTROENTEROLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

Stratification of liver fat content in non-alcoholic steatohepatitis patients with significant liver fibrosis using the MEFIB-Index and MRI-PDFF and its association with hepatocellular carcinoma, decompensation, and mortality

Sung Won Lee, Daniel Huang, Veeral Ajmera, Monica Tincopa, Jaclyn Bergstrom, Nabil Noureddin, Maral Amangurbanova, Harris Siddiqi, Egbert Madamba, Abdul Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Mazen Noureddin, Rohit Loomba

JOURNAL OF HEPATOLOGY (2023)

No Data Available